Supreme Court Rejects J&J's (JNJ) Request to Reinstate Ruling Against Abbott (ABT) -Bloomberg
Tweet
Share
E-mailGet Alerts JNJ Hot Sheet
Join SI Premium – FREE
The US Supreme Court rejected Johnson & Johnson's (NYSE: JNJ) request to reinstate a $1.67 billion win against Abbott Labs (NYSE: ABT) related to arthritis treatments.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler: PFA survey is most positive for Medtronic, Inc. (MDT)
- Greenland Mines announces 1-for-50 reverse split, field updates
- Xiao-I gets Nasdaq notice for falling below share value threshold
Create E-mail Alert Related Categories
Corporate News, LitigationSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
